Flu Vaccine 2006-2007 Strains To Be Determined By Advisory Cmte. Feb. 17
This article was originally published in The Pink Sheet Daily
The committee will hold annual meeting to decide the influenza strains for the upcoming flu season.
You may also be interested in...
Chiron's vaccines unit will operate as a separate division while its biopharmaceuticals unit will merge with Novartis' pharmaceutical business.
GlaxoSmithKline plans to acquire ID Biomedical for $1.4 bil., a deal that could provide GSK with a second flu vaccine in the U.S. for the 2006/2007 flu season.
Dr. Reddy's, GSK, Ranbaxy and UCB among manufacturers that could see prices reduced under government order that reflects issues raised in Gleevec patent dispute.